Acute Coronary Syndrome Review: 2026 Board Prep

You're in the ED, it's late, and the triage note says “chest pain.” A 58-year-old man with diabetes looks uncomfortable, sweaty, and pale. His first ECG is being printed. Before anyone says “rule out,” you already know the true question is simpler and more urgent. Is this acute coronary syndrome, and if it is, what fork in the road am I at right now?

That's why a good acute coronary syndrome review shouldn't just list definitions. It should train your reflexes. Boards test recognition, but the wards test decisions under uncertainty. The intern's mistake is thinking ACS is one diagnosis. The resident's mistake is thinking every case is obvious. The attending's job is to sort the patient into the right pathway fast, especially when the ECG, troponin, and story don't line up neatly.

Introduction to Acute Coronary Syndrome

Acute coronary syndrome (ACS) is the clinical spectrum of ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and unstable angina, and it remains a major burden worldwide. A JAMA review estimated that more than 7 million people worldwide are diagnosed each year, including more than 1 million hospitalizations in the U.S. alone (JAMA review on ACS burden and classification).

That matters for boards, but it matters even more at the bedside. You're not studying a zebra. You're studying one of the most common time-sensitive emergencies in medicine. The patient in front of you may need immediate cath lab activation, urgent invasive evaluation, or careful observation while you prove that the pain is something else.

A useful mental model is this: ACS is less about memorizing labels and more about answering three sequential questions.

1. Is there active myocardial ischemia?
2. Is there myocardial injury?
3. Does this patient need immediate reperfusion, early angiography, or monitored evaluation?

That third question is where people get tripped up. STEMI is often straightforward. The gray zone is not. Atypical symptoms, nondiagnostic ECGs, and an initial negative troponin can create false reassurance.

Board mindset: Chest pain questions are often really triage questions in disguise.

If you're preparing for shelf exams, USMLE, COMLEX, or an inpatient rotation, keep your framework tighter than your differential. A focused review style works better than a giant textbook chapter. If you want broader exam support beyond this topic, Ace Med Boards medical board review resources are built around that same high-yield approach.

Pathophysiology and Classification of ACS

ACS starts with coronary blood flow becoming unstable. The old oversimplification is “plaque ruptures, clot forms, artery blocks.” That's directionally right, but boards increasingly reward a cleaner understanding.

Contemporary pathology and intravascular imaging describe four major causal pathways: plaque rupture with inflammation, plaque rupture without inflammation, plaque erosion, and plaque without thrombus. Non-thrombotic ischemic mechanisms also matter, including coronary vasospasm and microcirculatory dysfunction (Circulation review on ACS mechanisms).

The artery as a cracked pipe

Think of a coronary artery like a pipe lined with unstable material. Over time, plaque builds. Then one of several things happens. The cap cracks, the surface erodes, or the vessel constricts enough to reduce flow. Platelets adhere, thrombus forms, and distal myocardium becomes ischemic.

That's why ACS isn't only a “blocked artery” disease. It's a supply-demand and plaque biology problem. Some patients have dramatic angiographic lesions. Others have confusing anatomy, transient occlusion, or even nonobstructive coronaries with true ischemic injury.

When the mechanism isn't clear, intravascular imaging or cardiac MRI can help sort out what happened. That's clinically useful in ambiguous lesions, myocarditis mimics, and cases that suggest MINOCA.

How boards classify ACS

For exam purposes, classify ACS using ECG findings plus cardiac biomarkers.

A simple memory line helps:

• STEMI = ST elevation + infarction
• NSTEMI = no ST elevation + infarction
• UA = ischemia without biomarker evidence of infarction

The practical distinction that changes treatment

The key difference isn't just naming the syndrome. It's what the naming implies.

• STEMI usually means an artery is acutely occluded enough to require immediate reperfusion.
• NSTEMI means myocardial necrosis happened, but the patient usually enters a risk-stratified invasive pathway rather than an automatic emergent one.
• Unstable angina is now less common in the troponin era, but it still matters on boards and in practice when symptoms are convincing yet biomarkers remain negative.

The dangerous student error is assuming “no ST elevation” means “not urgent.” It often means “different urgent.”

One useful cross-link for hemodynamics: ischemia reduces pump performance, increases filling pressures, and can rapidly change bedside physiology. If preload and afterload concepts still feel fuzzy, this quick review on preload and afterload helps connect ACS to shock, pulmonary edema, and medication choices.

Clinical Presentation and Initial Workup

Most students can recognize the classic presentation. Fewer recognize the common nonclassic one.

The classic story is substernal pressure or squeezing pain, often radiating to the arm, neck, jaw, or back, with diaphoresis, nausea, or dyspnea. But many ACS patients don't hand you that script. Older adults, patients with diabetes, and women may present with dyspnea, fatigue, epigastric discomfort, nausea, presyncope, or just “I don't feel right.”

What to ask in the first minute

A focused history should answer five things quickly:

• Character of symptoms. Pressure, tightness, heaviness, burning, or unexplained dyspnea all count.
• Time course. Sudden, progressive, intermittent, at rest, or exertional.
• Associated features. Diaphoresis, nausea, syncope, palpitations.
• Prior cardiac history. CAD, prior PCI, CABG, known angina.
• Risk context. Diabetes, smoking, hypertension, dyslipidemia, family history, cocaine or stimulant use.

Don't overvalue reproducible chest wall tenderness. It lowers suspicion a bit, but it doesn't rule out ACS. Don't overvalue relief with nitroglycerin either. Esophageal spasm can improve too.

What the exam can and can't do

The physical exam rarely diagnoses ACS by itself, but it changes urgency and broadens the differential.

Look for:

• Signs of heart failure such as rales, raised JVP, or an S3
• Shock physiology with cool extremities, hypotension, altered mentation
• Mechanical clues such as a new murmur, especially if acute MR or VSD is in play
• Alternative diagnoses like pulse deficits, tearing pain, unilateral leg swelling, fever, or focal lung findings

The first moves that matter

The early workup isn't glamorous. It's disciplined.

1. Place the patient on monitoring and get vitals
2. Obtain a 12-lead ECG immediately
3. Draw troponin
4. Get IV access and basic labs
5. Consider chest radiograph if the differential includes other thoracic pathology

A chest X-ray won't diagnose ACS, but it can support alternate diagnoses like pneumothorax, pneumonia, or widened mediastinum in the right setting.

Practical rule: The first ECG is a snapshot, not a verdict.

If the initial ECG is nondiagnostic and suspicion remains high, repeat it. Dynamic ischemia can declare itself over time. The same logic applies to troponin. Early ACS can hide on first draw, especially when the symptom timeline is short.

Mastering ECGs and Troponins in ACS

The ECG and troponin are the core diagnostic pair in any acute coronary syndrome review. Students often memorize findings without understanding what each test contributes. The ECG answers, “Is there an acute ischemic pattern right now?” Troponin answers, “Has myocardial injury occurred?”

Start with the ECG because it determines whether you're in a reperfusion emergency.

A rapid ECG approach that works on call

Read the ECG in this order:

1. Rate and rhythm
2. QRS and conduction issues
3. ST segments
4. T waves
5. Lead territory
6. Look for reciprocal changes
7. Compare with old ECG if available

For ACS, the highest-yield move is to localize the abnormality by contiguous leads.

This localization helps you think anatomically, but on boards, the immediate issue is usually management rather than naming the culprit artery.

STEMI versus mimic

Not every ST elevation is a STEMI. Common mimics include early repolarization, pericarditis, left ventricular hypertrophy, bundle branch block patterns, old aneurysmal changes, and myocarditis.

Helpful distinctions:

• Pericarditis tends to have diffuse ST elevation and PR depression rather than a focal territorial pattern.
• Early repolarization is often stable, seen in younger patients, and doesn't fit an ischemic story.
• LVH can produce secondary ST-T changes, especially in lateral leads.
• Posterior MI may hide as ST depression in anterior leads rather than obvious elevation.

This is where serial ECGs save you. A static mimic stays static. Active ischemia often evolves.

If you want a structured method for reading tracings under pressure, this stepwise guide to ECG reading steps is worth drilling.

Here's a quick visual refresher before going deeper:

How to think about troponin

Troponin is not a yes or no chest pain test. It's a myocardial injury marker. A single normal result doesn't exclude ACS if the patient presented early or if symptoms are ongoing.

What matters is the rise and fall pattern in the right clinical context.

• STEMI usually has a clear troponin rise, but you don't wait for troponin to activate reperfusion if the ECG is diagnostic.
• NSTEMI often depends on serial troponins plus symptoms and ECG findings.
• Unstable angina has ischemic symptoms without troponin elevation.

The gray-zone trap

Intermediate-risk patients often have some, but not all, of the pieces. Maybe the pain sounds ischemic, but the ECG is nondiagnostic. Maybe troponin is detectable but not clearly dynamic yet. Maybe the patient has recurrent symptoms with transient ECG changes.

That's where people either overcall everything or undercall danger.

Use this bedside logic:

• Worsening symptoms + dynamic ECG changes should raise your threshold for complacency.
• Persistently negative serial biomarkers make infarction less likely, but they don't erase unstable ischemia if the story is compelling.
• Alternative causes of troponin elevation exist, but they don't excuse you from assessing for ACS first.

A positive troponin means injury. It does not automatically tell you why.

That's especially important for myocarditis, tachyarrhythmia-related injury, renal disease, pulmonary embolism, and demand ischemia. Context always decides meaning.

Risk Stratification with TIMI and GRACE

Once you've ruled out obvious STEMI, the next decision is less dramatic and often harder. Who needs urgent angiography? Who can wait? Who can be observed and tested further?

This is the part of acute coronary syndrome review content that many learners find unsatisfying because the answer is often “it depends.” That's true, but only partly. You can still make the uncertainty manageable.

Recent review literature highlights a persistent gap in intermediate-risk and atypical patients, especially when ECG, troponin, and symptoms don't fit neatly and the need for early angiography remains uncertain (review on the gray zone in ACS risk stratification).

TIMI versus GRACE

A simple way to remember the difference:

• TIMI is faster and simpler.
• GRACE is broader and often stronger for prognosis.

What to do with the intermediate-risk patient

Scores help, but clinical judgment still leads.

Think in three buckets:

• Clearly high risk. Recurrent ischemia, dynamic ECG changes, positive biomarkers, hemodynamic instability, heart failure, or concerning ongoing symptoms. These patients lean toward early invasive management.
• Clearly low risk. Symptoms are less convincing, serial evaluation stays reassuring, and no objective high-risk feature emerges. These patients may move toward noninvasive testing or observation.
• Gray zone. Mixed story, nondiagnostic testing, maybe borderline troponin behavior, maybe atypical symptoms in a patient with real risk factors. This is the group that creates the most disagreement.

For that middle group, ask yourself:

• Are symptoms ongoing or recurrent?
• Are ECG findings dynamic, even if not classic?
• Is there another diagnosis that explains the presentation better?
• Is the patient someone I'd be uncomfortable sending away?

Boards pearl on using scores correctly

Boards like TIMI and GRACE because they force you to integrate data rather than chase a single test result. But the exams also like to punish rigid score worship.

A score is a tool, not an override. A patient with recurrent ischemic pain and evolving ECG changes doesn't become “safe” because the number looks modest. Likewise, a stable patient with low clinical suspicion doesn't become a cath lab candidate because one variable inflates a score.

If you want a quick refresher on the thinking behind diagnostic performance, this review of sensitivity and specificity pairs nicely with how these tools should be used.

Acute Management Algorithms from MONA to Reperfusion

Management starts before you've solved every ambiguity. You stabilize, identify the pathway, and move.

A JAMA review summarized the time-sensitive core nicely. Electrocardiography should be performed within 10 minutes of presentation, primary PCI within 120 minutes for STEMI lowered mortality from 9% to 7%, and for high-risk NSTE-ACS, invasive coronary angiography and revascularization within 24 to 48 hours reduced death from 6.5% to 4.9% (summary of the JAMA ACS review).

First medications at the bedside

The old mnemonic is MONA-B. It's still useful if you understand its limits.

• Morphine. Reserve it for severe persistent pain when other measures aren't enough. It isn't routine comfort candy.
• Oxygen. Give it for hypoxemia or respiratory distress. Don't reflexively place everyone on oxygen.
• Nitroglycerin. Helpful for ischemic discomfort and hypertension. Avoid it when preload dependence is a concern, such as suspected right ventricular infarction or significant hypotension.
• Aspirin. Give it early unless there's a clear contraindication.
• Beta-blocker. Often used early if the patient is hemodynamically stable and doesn't have contraindications.

The STEMI fork

The STEMI pathway is the easiest branch conceptually and the most unforgiving in real life.

If the ECG shows a reperfusion-requiring pattern and the story fits, activate for primary PCI. That's preferred when it can be delivered within the treatment window noted above. If PCI isn't available promptly, fibrinolysis may enter the conversation depending on the setting and contraindications, but for boards the preferred answer is usually PCI when feasible.

A simple STEMI memory line:

Open the artery fast. Don't wait for the troponin to prove what the ECG already told you.

The NSTE-ACS fork

NSTEMI and unstable angina are where management becomes layered rather than reflexive.

Treat the patient medically up front, then decide on timing of angiography based on risk. The high-risk patient moves toward an early invasive strategy. The low-risk patient may undergo observation and noninvasive evaluation. The intermediate-risk patient requires actual judgment.

Use this bedside algorithm for gray-zone NSTE-ACS:

1. Confirm serial ECGs and serial troponins
2. Look for recurrent symptoms despite initial therapy
3. Check for instability such as hypotension, pulmonary edema, or malignant arrhythmia
4. Identify dynamic ischemic evidence, even if subtle
5. Escalate to early angiography when the trajectory worries you more than the snapshot reassures you

Antithrombotic thinking

You'll usually see two pharmacologic categories in early ACS treatment:

• Antiplatelet therapy, including aspirin and a P2Y12 inhibitor
• Anticoagulation, such as heparin-based therapy depending on the strategy

Boards often test the concept, not the exact preferred agent in every niche scenario. What they want you to know is that ACS treatment aims to limit clot propagation while you decide on or proceed to reperfusion.

Three common management mistakes

• Waiting on a biomarker in obvious STEMI
• Giving oxygen without hypoxemia just because chest pain feels scary
• Underestimating the recurrent-pain NSTEMI patient because the first ECG looked unimpressive

The patient who keeps having pain is telling you something. Listen.

Inpatient and Long-Term Post MI Care

Opening the artery is the beginning of care, not the end of it. Post-MI management is where you reduce recurrent events, protect ventricular function, and keep the patient from bouncing right back into the hospital.

The discharge medication checklist

For most post-MI patients, think in medication groups rather than brand names first.

• Dual antiplatelet therapy. Aspirin plus a P2Y12 inhibitor, unless contraindications or procedural factors change the plan.
• High-intensity statin. This is standard secondary prevention thinking.
• Beta-blocker. Especially important when ischemia, arrhythmia risk, or LV dysfunction is part of the picture.
• ACE inhibitor or ARB. Particularly valuable in patients with LV dysfunction, hypertension, diabetes, or anterior infarction patterns.
• Aldosterone antagonist. Used selectively, not universally.

A practical discharge note should also document why a usual medication was omitted. Boards and attendings both care about that.

What to address before the patient leaves

Don't let the discharge process become a medication printout with no teaching. Patients need to understand the disease they just survived.

A strong discharge conversation includes:

• Medication adherence
• Smoking cessation
• Blood pressure and diabetes control
• Diet and exercise counseling
• Cardiac rehabilitation referral
• Return precautions for chest pain, dyspnea, syncope, or worsening edema

The post-MI patient doesn't just need prescriptions. They need a new default plan for daily life.

Common patient questions you should answer well

Patients usually ask some version of:

• “When can I walk or exercise?”
• “Do I need to change my diet?”
• “What happens if I miss a pill?”
• “How will I know if this pain is dangerous again?”

Those are high-value conversations. They improve adherence because they convert instructions into usable decisions.

For patients and families trying to understand where advanced cardiac care is available, especially during transfer planning or second-opinion discussions, a practical public-facing resource like Med Jets' picks for cardiac hospitals can be helpful.

One inpatient pearl residents forget

Don't stop thinking about complications just because the cath is over. Monitor rhythm, volume status, oxygenation, recurrent pain, and new murmurs. A patient can look “post-PCI stable” and still declare heart failure, arrhythmia, reinfarction, or a mechanical complication.

High-Yield Complications Differentials and Board Pearls

Boards love ACS, but they love ACS complications even more. The trick is to organize them by what kills fast, what appears later, and what mimics the whole presentation.

Complications to know cold

Electrical problems often come early:

• Ventricular arrhythmias
• Bradyarrhythmias
• AV block, especially with inferior involvement

Mechanical and inflammatory complications become the classic “sudden turn” questions:

• Papillary muscle rupture with acute mitral regurgitation
• Ventricular septal rupture
• Free wall rupture with tamponade physiology
• Pericarditis
• Heart failure or cardiogenic shock

A useful exam habit is to connect each sudden deterioration to a clue:

• New murmur plus pulmonary edema. Think acute MR.
• Shock plus harsh murmur. Think VSD.
• PEA or sudden collapse after MI. Think free wall rupture.

Can't-miss chest pain differentials

Not all bad chest pain is ACS.

If the patient is in respiratory distress, widening the frame matters, as chest pain and respiratory failure can overlap quickly. For a quick refresher on escalation principles, this review of respiratory failure treatment is a useful companion topic.

Board pearls that stick

• A normal first troponin doesn't rule out ACS.
• A diagnostic STEMI ECG doesn't need troponin confirmation before action.
• Unstable angina still exists. Think ischemic symptoms without biomarker elevation.
• Recurrent pain changes risk.
• A new murmur after MI is never casual.
• Hypotension after nitrates should make you think about preload dependence.

If you like building your own teaching summaries, diagrams, or review clips before an exam block, this AI-powered video learning guide can help turn dense topics like ACS into short recall tools.

Two board-style questions

Question 1

A patient presents with ongoing chest pressure, diaphoresis, and an ECG showing persistent ST-segment elevation in contiguous leads. The initial troponin hasn't resulted yet. What is the best next step?

Answer: Activate urgent reperfusion pathway.

Why: In a clear STEMI pattern, the ECG drives immediate action. Waiting for troponin delays care. The test result may support the diagnosis later, but it shouldn't gate treatment.

Why the wrong answers are wrong:

• Repeat troponin first delays reperfusion.
• Stress testing is inappropriate in active ACS.
• Discharge with follow-up is dangerous.

Question 2

A patient has chest discomfort, a nondiagnostic initial ECG, and an initial troponin that isn't increased. The pain recurs during observation, and a repeat ECG shows new ischemic changes. What's the most important implication?

Answer: The patient's risk has increased and management should escalate.

Why: Dynamic symptoms plus dynamic ECG findings matter even when the first snapshot was inconclusive. This is the classic gray-zone patient who becomes less gray over time.

Why the wrong answers are wrong:

• Calling it noncardiac because the first troponin was negative ignores troponin kinetics.
• Reassuring yourself because there's no STEMI misses NSTE-ACS danger.
• Relying only on a risk score ignores evolving bedside data.

The best acute coronary syndrome review is the one that changes your next decision. If you can identify the syndrome, recognize the mimic, and handle the intermediate-risk fork without freezing, you're thinking like someone who can pass boards and take care of real patients.

If you want structured, case-based help mastering ACS and other high-yield topics for USMLE, COMLEX, and shelf exams, Ace Med Boards offers one-on-one tutoring built around clinical reasoning, board-style questions, and practical test-taking strategy.